Antinuclear antibody titer and antibodies to extractable nuclear antigens [2]

Arthritis Care and Research

Volumn 53, Issue 6, 2005, Pages 987-988

  Bossuyt, Xavier ^a   Hendrickx, Ann ^a   Frans, Johan ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; CELL NUCLEUS ANTIGEN; DNA ANTIBODY; RIBONUCLEOPROTEIN ANTIBODY; SCL 70 ANTIBODY; SM ANTIBODY;

ANTIBODY SPECIFICITY; ANTIBODY TITER; ANTIGEN ANTIBODY REACTION; DISEASE ACTIVITY; HUMAN; HUMAN CELL; LETTER; STAINING;

ANTIBODIES, ANTINUCLEAR; ANTIGENS, NUCLEAR; EVIDENCE-BASED MEDICINE; FALSE POSITIVE REACTIONS; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOLOGIC TESTS; RHEUMATIC DISEASES; RHEUMATOLOGY;

EID: 29144455387     PISSN: 21514658     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.21602     Document Type: Letter

References (4)

1. Solomon DH, Kavanaugh AJ, Schur PH, and the American College of Rheumatology and Ad Hoc Committee on Immunologic Testing Guidelines. Evidence-based guidelines for the use of immunologic tests: antinuclear antibody testing. Arthritis Rheum 2002;47:434-44.
2. Peene I, Meheus L, Veys EM, De Keyser F. Detection and identification of antinuclear antibodies (ANA) in a large and consecutive cohort of serum samples referred for ANA testing. Ann Rheum Dis 2001;60:1131-6.
3. Homburger HA. Cascade testing for autoantibodies in connective tissue diseases. Mayo Clin Proc 1995;70:183-4.
4. Dawkins RL, Martinez OP, Freitas EM, Hollingsworth PN. Diagnosis of autoimmune disease. In: Rose NR, Mackay IR, editors. The autoimmune diseases. 3rd ed. San Diego: Academic Press; 1998. p. 821-31.